BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research

"The investigational NurOwn technology platform currently in Phase 3 and Phase 2 for ALS and progressive MS, respectively, have life changing potential.